Scudamore C L, Pemberton A, Watson E D, Miller H R
Department Veterinary Clinical Studies, Royal (Dick) School of Veterinary Studies, Easter Bush, Roslin, Midlothian.
Br Vet J. 1993 Jul-Aug;149(4):331-8. doi: 10.1016/S0007-1935(05)80074-0.
Studies have demonstrated that as a result of proteolytic inactivation or complex formation (with neutrophil elastase), human alpha-1-proteinase inhibitor (API) becomes a potent chemoattractant for human neutrophils. The present study aimed to investigate the in vitro chemotactic response of equine neutrophils to an equivalent complex of equine API and neutrophil elastase. No evidence of neutrophil migration was observed towards purified complex derived from equine neutrophil elastase and the Spi 1 isoform of equine API, or to crude mixtures of porcine pancreatic elastase and unseparated equine API isoforms, although the same neutrophil preparations actively migrated towards zymosan activated plasma. It was concluded that, in the horse, complexes of API are not involved in the migration of neutrophils to sites of inflammation.
研究表明,由于蛋白水解失活或形成复合物(与中性粒细胞弹性蛋白酶),人α-1蛋白酶抑制剂(API)成为人中性粒细胞的一种强效趋化剂。本研究旨在调查马中性粒细胞对马API和中性粒细胞弹性蛋白酶等效复合物的体外趋化反应。未观察到中性粒细胞向源自马中性粒细胞弹性蛋白酶和马API的Spi 1同种型的纯化复合物,或向猪胰弹性蛋白酶和未分离的马API同种型的粗混合物迁移的证据,尽管相同的中性粒细胞制剂会向酵母聚糖激活的血浆积极迁移。得出的结论是,在马中,API复合物不参与中性粒细胞向炎症部位的迁移。